The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Is hyperprogressive disease a specific phenomenom of immunotherapy?”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Martin Reck, Nikolaj Frost, Solange Peters, Bernard A. Fox, Roberto Ferrara, Rajkumar Savai, Fabrice Barlesi. Treatment of NSCLC after chemoimmunotherapy — are we making headway?, Nature Reviews Clinical Oncology. 2025; https://doi.org/10.1038/s41571-025-01061-7 |
|
2 |
2022 |
Mohammad Alkader, Rashed Altaha, Lean Alkhatib , Eslam H Jabali, Mohammad S Alsoreeky. Hyperprogressive Disease In a Metastatic Renal Cell Carcinoma Patient After Receiving Immune Checkpoint Inhibitors: A Case Report, Cureus. 2022; https://doi.org/10.7759/cureus.30194 |